Sign in
Taking people in United StatesNo phase

Following people with multiple sclerosis over many years to learn about their disease

Observes people with multiple sclerosis over many years to understand how the disease changes.

Key facts

Who runs it
University of Pittsburgh
Where
Pittsburgh, United StatesSee the site
Trial code
Registry title
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
Status
Recruiting
People taking part
7,500 people, planned
Started
Dec 2016
Expected to end
Jan 2047
Type of study
Observational, 2 groups
Record updated
29 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with multiple sclerosis or related disorders, and also healthy volunteers as controls. All must be 7 years or older.

Age
7 years or older
Sex
All sexes can join.
Disease stage
Multiple sclerosis or related disorders. This includes a first episode of nervous system demyelination with a positive MRI scan, or MS-like MRI scans with no symptoms.

Main reasons for not taking part

  • The record lists no exclusion criteria.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Inclusion criteria for MS patients include:; Age 7 years or older; Willing and able to provide consent (for >=18 years) or assent with permission from at least one of the child's parents (for <18 years); Diagnosis of multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
  • For healthy controls:; Age 7 years or older; Willing and able to provide consent (for >=18 years) or assent with permission from at least one of the child's parents (for <18 years); No known personal history of multiple sclerosis or related disorders; No other chronic diseases; Family members, unrelated household controls, or controls from the general population could be eligible; There is no exclusion criteria

Where in United States

  • University of PittsburghPittsburgh, United StatesContact: Zongqi Xia, MD, PhDTaking people

About the trial

What the trial wants to find out

In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.

The 2 groups in the trial

  • People with Multiple Sclerosis or Related Disorders

    Individuals must be 7 years or older, diagnosed with multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease

  • People without Multiple Sclerosis or Related Disorders

    Control participants must be 7 years or older, have no known personal history of multiple sclerosis or related disorders, no other chronic disease, and can be a family member, unrelated household control, or control from the general population.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
Plain-language title
Following people with multiple sclerosis over many years to learn about their diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
29 December 2025